HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket
Henry Schein, Inc. HSIC registered adjusted earnings per share (EPS) of $1.22 in the third quarter of 2024, down 7.6% from the year-ago figure. However, the metric exceeded the Zacks Consensus Estimate...
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket
Bio-Rad Laboratories, Inc. BIO posted third-quarter 2024 adjusted earnings per share (EPS) of $2.01, which beat the Zacks Consensus Estimate by 57%. However, the bottom line decreased 13.7% from the prior-year...
WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action
Walgreens Boots Alliance, Inc. WBA delivered adjusted earnings per share (EPS) of 39 cents in the fourth quarter of fiscal 2024, down 41.8% from the year-ago quarter’s figure (down 40.8% at constant...
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?
The genetic test maker is rapidly increasing test volumes.